As of 2025-07-01, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (44.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -275.5%.
The range of the Relative Valuation is (36.55) - (50.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 15.1x - 22.8x | 19.0x |
Forward P/E multiples | 16.6x - 27.1x | 21.8x |
Fair Price | (36.55) - (50.11) | (44.92) |
Upside | -242.8% - -295.8% | -275.5% |
Date | P/E |